Health care stocks were advancing premarket Thursday with the Health Care Select Sector SPDR Fund (XLV) 0.4% higher and the iShares Biotechnology ETF (IBB) also up 0.4%.
Cooper (COO) shares rose past 6% after it reported higher fiscal Q3 non-GAAP earnings and net sales. The company also raised its guidance for fiscal 2024 non-GAAP earnings per share.
BioCardia (BCDA) shares rallied by 95% after saying the US Food and Drug Administration cleared the company to market its Morph DNA Steerable Introducer product family.
Catalent (CTLT) shares were up more than 1% after it reported higher fiscal Q4 adjusted earnings and net revenue.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments